Home > Insider Trading > Filing (0001209191-14-068926)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1142596	Nuvasive Inc	NUVA	Surgical & Medical Instruments & Apparatus (3841)	330768598

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1242610	M Eileen More	7475 Lusk Blvd. San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-05-22	18,000	$25.89	34,833	No	4	M	Direct
Common Stock	Disposition	2014-05-22	18,000	$43.60	16,833	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2007-06-06	18,000	$0.00	18,000	$25.89

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2017-06-06	No	4	M	Direct

Footnotes

Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive or purchase (as appropriate) shares pursuant to previously disclosed Company equity awards.
Weighted average from 162 transactions with prices ranging from $43.4100 to $43.7350. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
The option, representing a right to purchase a total of 18,000 shares, became exercisable as follows: 15,000 shares were vested and exercisable as of the date of grant (June 6, 2007) and the remaining 3,000 shares vested and became exercisable in 24 equal monthly installments beginning June 6, 2007, so that all shares were fully vested as of June 6, 2009, subject to continued service as a Director of NuVasive, Inc. through each vesting period.